Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1976 1
1977 1
1978 2
1979 1
1980 1
1984 2
1985 4
1986 1
1987 1
1988 1
1989 3
1990 3
1991 4
1992 5
1993 1
1994 3
1995 2
1996 2
1997 4
1998 2
1999 6
2000 9
2001 4
2002 6
2003 8
2004 6
2005 5
2006 9
2007 2
2008 5
2009 3
2010 6
2011 2
2012 11
2013 16
2014 12
2015 16
2016 13
2017 17
2018 17
2019 9
2020 11
2021 17
2022 14
2023 28
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management.
Ansell SM. Ansell SM. Am J Hematol. 2022 Nov;97(11):1478-1488. doi: 10.1002/ajh.26717. Epub 2022 Sep 19. Am J Hematol. 2022. PMID: 36215668 Free article.
DISEASE OVERVIEW: Hodgkin lymphoma (HL) is an uncommon B-cell lymphoid malignancy affecting 8540 new patients annually and representing approximately 10% of all lymphomas in the United States. ...Patients with early-stage disease are typically treated with combined …
DISEASE OVERVIEW: Hodgkin lymphoma (HL) is an uncommon B-cell lymphoid malignancy affecting 8540 new patients annually and representi …
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7. Lancet Oncol. 2022. PMID: 35772465 Free PMC article. Review.
Key recommendations (grade 1A or 1B) include: (1) low-molecular-weight heparins (LMWHs) for the initial (first 10 days) treatment and maintenance treatment of cancer-associated thrombosis; (2) direct oral anticoagulants for the initial treatment and maintenance treatment of cance …
Key recommendations (grade 1A or 1B) include: (1) low-molecular-weight heparins (LMWHs) for the initial (first 10 days) treatment and mainte …
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Surgery and/or radiotherapy may be indicated for symptomatic lesions or tumors causing local organ dysfunction or obstruction. Allogeneic hematopoietic stem cell transplantation has demonstrated promising results, particularly in patients who achieved complete remission wi …
Surgery and/or radiotherapy may be indicated for symptomatic lesions or tumors causing local organ dysfunction or obstruction. Alloge …
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.
Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A; International Lymphoma Radiation Oncology Group. Illidge T, et al. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):49-58. doi: 10.1016/j.ijrobp.2014.01.006. Int J Radiat Oncol Biol Phys. 2014. PMID: 24725689 Free article.
Radiation therapy (RT) is the most effective single modality for local control of non-Hodgkin lymphoma (NHL) and is an important component of therapy for many patients. ...The roles of reduced volume and reduced doses are addressed, integrating modern …
Radiation therapy (RT) is the most effective single modality for local control of non-Hodgkin lymphoma (NHL) and is an …
Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, Girinsky T, Hoppe RT, Mauch P, Mikhaeel NG, Ng A; ILROG. Specht L, et al. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):854-62. doi: 10.1016/j.ijrobp.2013.05.005. Epub 2013 Jun 18. Int J Radiat Oncol Biol Phys. 2014. PMID: 23790512
Radiation therapy (RT) is the most effective single modality for local control of Hodgkin lymphoma (HL) and an important component of therapy for many patients. ...Newer treatment techniques, including intensity modulated radiation therapy, brea …
Radiation therapy (RT) is the most effective single modality for local control of Hodgkin lymphoma (HL) and an importan …
Staging and response assessment in lymphomas: the new Lugano classification.
Cheson BD. Cheson BD. Chin Clin Oncol. 2015 Mar;4(1):5. doi: 10.3978/j.issn.2304-3865.2014.11.03. Chin Clin Oncol. 2015. PMID: 25841712 Free article. Review.
After years of experience with these criteria, a workshop including representatives of most major international lymphoma cooperative groups and cancer centers was held at the 11(th) International Conference on Malignant Lymphoma (ICML) in June, 2011 to determine wha …
After years of experience with these criteria, a workshop including representatives of most major international lymphoma cooperative …
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M, DeSantes K, Kelly K, Kitko C, Lacayo N, Larrier N, Maese L, Mahadeo K, Nanda R, Nardi V, Rodriguez V, Rossoff J, Schuettpelz L, Silverman L, Sun J, Sun W, Teachey D, Wong V, Yanik G, Johnson-Chilla A, Ogba N. Brown P, et al. J Natl Compr Canc Netw. 2020 Jan;18(1):81-112. doi: 10.6004/jnccn.2020.0001. J Natl Compr Canc Netw. 2020. PMID: 31910389
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Advancements in technology that enhance our understanding of the biology of the disease, risk-adapted therapy, and enhanced supportive care have contributed to improved survival rates …
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Advancements in technology that enhance our understanding …
Management of marginal zone lymphomas.
Merli M, Arcaini L. Merli M, et al. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):676-687. doi: 10.1182/hematology.2022000362. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485086 Free PMC article.
Marginal zone lymphomas (MZLs) represent about 7% of B-cell non-Hodgkin lymphomas and include 3 different subtypes-namely, extranodal (EMZL), nodal, and splenic (SMZL). ...Involved-site radiotherapy has a central role in the management of localized EMZL not a …
Marginal zone lymphomas (MZLs) represent about 7% of B-cell non-Hodgkin lymphomas and include 3 different subtypes-namely, ext …
Management of primary and secondary CNS lymphoma.
Khwaja J, Cwynarski K. Khwaja J, et al. Hematol Oncol. 2023 Jun;41 Suppl 1:25-35. doi: 10.1002/hon.3148. Hematol Oncol. 2023. PMID: 37294958
Central nervous system (CNS) lymphoma has traditionally had very poor outcomes however advances in management have seen dramatic improvements and long-term survival of patients. In primary CNS lymphoma there are now randomised trial data to inform practice, h …
Central nervous system (CNS) lymphoma has traditionally had very poor outcomes however advances in management have seen dramat …
Recent advances in treatment of nodal and gastrointestinal follicular lymphoma.
Watanabe T. Watanabe T. World J Gastroenterol. 2023 Jun 21;29(23):3574-3594. doi: 10.3748/wjg.v29.i23.3574. World J Gastroenterol. 2023. PMID: 37398889 Free PMC article.
In contrast, in Europe and the United States, gastrointestinal FL has long been considered to be present in 12%-24% of Stage-IV patients, and the number of advanced gastrointestinal cases is expected to increase. This editorial provides an overview of the recent therape …
In contrast, in Europe and the United States, gastrointestinal FL has long been considered to be present in 12%-24% of Stage-IV patients, an …
271 results